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Shortages and imbalances of human resources for health
(HRH) are a major crisis in numerous countries across all
health professions.1 To tackle the workforce crisis, solid
information, reliable research, and firm knowledge are
required to form effective policies and actions. In the 2006
World Health Report, a worker-lifespan approach was sug-
gested to strengthen policy strategies in preparing the
workforce, enhancing performance, and managing attrition
and migration.2 An integrated view of each stage of a
professional career is necessary in the management and
development of human resources of the health professions.
Being a major HRH, the pharmacy workforce has expe-
rienced a shortage and distributional imbalance in devel-
oping and developed countries.3 In Taiwan, the pharmacy
workforce, including pharmacists and pharmaceutical as-
sistants, has experienced significant growth over the past 2
decades. The ratio of current pharmacy workforce to pop-
ulation increased from 8.8/10,000 in 1990 to 14.0/10,000 in
2010, which is higher than that of most Organization for
Economic Cooperation and Development countries.3,4* Corresponding author. Institute of Population Health Sciences,
National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli
County 350, Taiwan.
E-mail address: hsiung@nhri.org.tw (C.A. Hsiung).
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http://dx.doi.org/10.1016/j.jfma.2013.07.016However, the present proportion in the total supply of the
pharmacy workforce does not necessarily meet an
adequate workforce in the future because an aging work-
force and aging population can cause fluctuations in work-
force supply and demand.
Task force for projection of pharmacy
workforce
For evidence-informed decision making, a cooperative
framework between policymakers and researchers is
necessary to form a policy or action in HRH. Since 2010, the
National Health Research Institutes and the Bureau of Med-
ical Affairs, Department of Health, has been coupled to
conduct a series of studies to forecast the health workforce
for various health professions. The pharmacy workforce was
targeted for the first year. This study is composed of two
parts. First, a task force, including stakeholders, such as
government representatives, faculties from the pharma-
cology departments in universities, clinical and managerial
pharmacists working in hospitals, and representatives of the
pharmacist association, was organized to outline a plan and
discuss the following issues: clarify the main purpose; detail
policy and practice environment, frame the scope of the
research, confirm the approach, offer access to databases,
provide the required parameters, and contribute to inter-
preting and reviewing the results. The second part formed a
projection team, mainly composed of National Health& Formosan Medical Association. All rights reserved.
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collection, analysis, and presenting and interpreting the
results. The task force and projection team regularly inter-
acted with each other. The main purpose of the projection is
to forecast whether shortages or excesses will exist in the
pharmacy workforce in the coming decade 2011e2020. On
the supply side, the inventory model was introduced, and
entrant and attrition flows of the workforce were estimated
using the official registration data of medical practitioners.5
Sensitivity analysis for six scenarios was provided to assess
the effects of new entrants, attrition, or returner flows on
the results. As far as demand is concerned, clinical phar-
macists (CPs) and nonclinical pharmacists (NCPs) were
considered separately. The demand for CPs was estimated
by forecasting the future volume of pharmaceutical care
based on the National Health Insurance Research Database
and the official population projections. The demand for
NCPs was modeled on the time trend of national medical
expenditures spent on over-the-counter drugs in drug stores.Supply, demands, and their determinants of
pharmaceutical works
The projection indicated that the supply of pharmaceutical
workers will be 35,635 by 2020. The demand for CPs and
NCPs was 28,246 and 8075, totaling 36,321. Sensitivity
analysis was used to examine the effectiveness of work-
force development strategies in managing entrants,
retention, and attrition of the workforce. The attrition rate
is the predominant factor for determining supply: a 1%
decrease in attrition flow will lead to a 0.45% increase in
supply by 2020 (equivalent to 161 pharmacists), followed by
a returning workforce (0.32% increase, or 115 pharmacists),
outstripping new entrants (0.26% increase, or 94 pharma-
cists). Supply is exceeding demand until 2018; a 0.2e2.8%
shortage, comparing supply and demand, will occur by
2020. How to control attrition might be the most crucial
and urgent issue in the development of the pharmacy
workforce in the coming decade.
A demographic transition of the pharmacy workforce will
occur in the next decade. More than 13% of theworkforcewill
be supplied by pharmacists aged 65 years and older in 2020
compared to that of 6% in 2010. According to the registration
data between 2001 and 2010, pharmacists aged 50 years and
over tend to practice in community pharmacies (36.9%) and
retailer, academic, or industrial (30.3%), and younger phar-
macists tend toworkmore inhospitals (28.9%) and community
pharmacies (28.0%). The increasing supply of female phar-
macists, especially among theworkforce aged<40 years, will
contribute 60.6% of the younger workforce by 2020. Female
healthcare professionals were thought to have lower labor
force participation during their childbearing years because of
their traditional familial roles.6 The supply projection, how-
ever, suggested lower attrition rates for female pharmacists
than men among the workforce aged <50 years.Limitations
The demand projection was developed based on current
utilizations and practice patterns, which may not considerthe potential changes of pharmacists’ roles in the future.
Because the population is aging and older adults tend to use
multiple drugs,7 pharmacists may be required to offer pa-
tient counseling, disease management, and adverse effect
assessment for older adults with multiple chronic condi-
tions.8 Beside clinical service, hospital-based health pro-
fessionals are responsible for teaching and research,9 which
raises additional demand for hospital pharmacists. A growth
in research positions in the industrial or academic sector
involved in clinical or translational research may also occur
to develop new treatment or biotechnology.10 These two
causes, which were not fully captured in the projection,
might offer more opportunities in the pharmacy profession
in the future.
This workforce projection, bridging the gap between
policy making and research evidences, provided the un-
derstanding of and the insight into future scenarios. It also
calls for action to reduce attrition and to augment reten-
tion of pharmaceutical workers. This requires collaborative
efforts and knowledge inputs of policy makers, researchers,
and stakeholders to review policy options and to develop
evidence-based workforce strategies. The present projec-
tion reflects what occurred in the past onto the long-term
future. Its assumptions should be regularly reviewed, and
the outcomes should be repeatedly updated by the national
plans for the pharmaceutical human resources.References
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